Sense of Coherence and Empowerment at Patients With MUPS

Not Applicable

Recruiting

• Conditions: Medically Unexplained Symptoms; Sense of Coherence
• Interventions: Behavioral: Metacognitive Therapy

• Registration Number: NCT05121922
• Lead Sponsor: University of Oslo

Brief Summary

This is a study on Metacognitive therapy in general practice in Norway. The intervention is a small pilot study to examine whether Metacognitive therapy is feasible in an ordinary general practice. Will the physicians be capable to learn and provide the therapy method for their patients with MUPS and is is possible to implement this in an ordinary general practice routine? Both physicians and their patients will be asked to respond to a questionnaire on perceived utility of the treatment.

Detailed Description

Metacognitive therapy is different from Cognitive therapy in the sense that it adresses the individual's attention towards potential worries and threats and also the management performed by the patient to avoid these. Also the individual's capacity to produce empowerment to manage these threats are of interest in the talks with the health care provider. - In this study, General Practitioners with specific training in Metacognitive therapy will be asked to recruit 2-3 patients with Medically Unexplained Physical Symptoms each and invite them to a series of Metacognitive Therapy. The patients and physicians will then provide their assessments of the treatment on a number of questionnaires. To explore the Sense of coherence and Empowerment among patients with Medically Unexplained Symptoms, the physicians will be asked to recruit six patients each to respond to a questionnaire.

Study Timeline

• Study Start: 2021-08-15
• Study First Submitted: 2021-10-19
• Study First Submitted QC: 2021-11-13
• Study First Posted: 2021-11-16
• Status Verified: 2022-11
• Last Update Submitted: 2022-11-08
• Last Update Posted: 2022-11-09
• Primary Completion: 2023-06-30
• Study Completion: 2025-06-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• MUPS: Medically Unexplained Physical Symptoms
• somatic and mental examination sufficiently accomplished
• ongoing symptoms
• more than three months of disabeling symptoms

Exclusion Criteria

• not capable to respond on a written questionnaire in Norwegian

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Intervention	Metacognitive Therapy	All patients recieve active treatment

Primary Outcome Measures

Name	Time	Method
Feasibility in daily practice	One year	The physicians will record the number of patients that agree to participate and complete the treatment

Secondary Outcome Measures

Name	Time	Method
Effect of metacognitive therapy	One year	Participating patients will respond on The Short Form Health Survey RAND-36 at start and at the end of the treatment. A reduced score indicates improvement of symptom burden.

Trial Locations

Locations (1)

University of Oslo; 🇳🇴 Oslo, Norway